Ignite Creation Date:
2024-05-06 @ 10:43 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03333694
Status:
TERMINATED
Last Update Posted:
2020-12-11
First Post:
2017-10-12
Brief Title:
Safety Tolerability and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ SCCis
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-12-15
Start Date Type:
ACTUAL
Primary Completion Date:
2018-11-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-11-01
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-12
First Submit QC Date:
November 3 2017
Study First Post Date:
2017-11-07
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-12-09
Last Update Post Date:
2020-12-11
Last Update Post Date Type:
ACTUAL